81
53
Growth Score 81 in past quarter
-4 pts
Heat Score 53 in past quarter
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
265398
Futrue is a pharmaceutical firm that offers clinical data using a developed algorithm, promoting chemical-free drugs and medical cannabis.
- David Rietbrock: Chief Operating OfficerPast Role: McKinsey & Company, Associate Partner
- Bastian Baasch: CEO FUTRUE Research & Science & VERTANICALPast Role: University of Kiel, Student Researcher
About the Company
FUTRUE is more than just an internationally oriented healthcare group! With over 20 companies and more than 90 drug approvals, we are global leaders in areas such as e-health, microbiome therapy, innovative pain therapies, and chemical-free medicines. Many of our companies, including SYNformulas and Vertanical, are among the fastest-growing
healthcare companies in the world. To continue this success, we are relying on a new generation of dynamic talent who have the courage to break new ground. Our goal is to give as many people as possible a new lease on life!